Randomized Data To Support Screening Mammography Lacking - Horton
This article was originally published in The Gray Sheet
Executive Summary
Reliable evidence from randomized trials is needed to support screening mammography programs, Richard Horton, MD, editor of the Lancet, concludes in an Oct. 20 commentary in the UK medical journal. "For a full independent overview to be completed, principal investigators of all component randomized trials will have to supply individual patient data," Horton asserts.